CVE-2025-41257: Suprema BioStar 2 · Improper Input Validation
Affects Suprema BioStar 2Source CVE Database V5
Not known to be exploited · CVSS 4.8 Medium.
Data as of 30 Oct 2026, 11:52 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 17% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 4 Mar 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 30 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| SupremaBioStar 2 | Affected
| Fixed in– |
AI-suggested
Organizations should immediately assess their use of Suprema BioStar 2 version 2.9.11.6 and plan to upgrade to a patched version once available. Until a patch is released, implement strict network segmentation and firewall rules to restrict access to the BioStar 2 management interfaces to trusted administrators only. Enable multi-factor authentication (MFA) for all administrative accounts to reduce the risk of unauthorized access. Monitor system logs for unusual password reset activities or access patterns indicative of exploitation attempts. Conduct regular audits of user accounts and permissions to detect unauthorized changes. If possible, disable remote password reset functionality or require additional verification steps to strengthen authentication. Engage with Suprema support for guidance and early access to patches or workarounds. Finally, incorporate this vulnerability into incident response plans to ensure rapid detection and containment if exploitation occurs.
Description
Suprema’s BioStar 2 in version 2.9.11.6 allows users to set new password without providing the current one. Exploiting this flaw combined with other vulnerabilities can lead to unauthorized account access and potential system compromise.